We read with interest the paper by Rawat et al1 related to the role of bilevel positive airway pressure (BiPAP) delivered via endotracheal tube in unconscious patients suffering from acute exacerbations of chronic obstructive pulmonary disease in a real-world situation. Although the authors provide some justification for the use of BiPAP through an endotracheal tube, we believe that this technique is fraught with complications and should not be routinely employed. In fact, three patients failed BiPAP therapy, two patients received conventional invasive ventilation, and one patient failed to respond to BiPAP. Thus, almost 30% of patients either failed or showed no evidence for benefit of BiPAP. Further, the authors provide no data on the amount of leakage that was present while administering BiPAP therapy. The authors also do not provide details on whether the nurses/chest therapist administered intermittent manual bag ventilation. Ideally, the authors should have referred the patients on manual bag ventilation to another public health center where facilities for invasive ventilation are available free of cost.From a physiological standpoint, assist-control mode is preferred in patients with severe acidosis and exacerbation of chronic obstructive pulmonary disease. The BiPAP mode has advantages only with an intact drive (not apnea). Thus, in patients with a decreased level of consciousness or apnea, we may suppose that the assist-control mode is more effective for achieving effective muscular rest and ventilation, as shown by Nava et al.2 Application of high positive pressures alone does not guarantee an adequate tidal volume.3 Moreover, there is no definite relationship between high pressure levels and adequate washout of pCO2. Finally, the authors provide no explanation regarding the failure of therapy in nonresponders, but believe that the device delivered an adequate amount of positive pressure.In summary, although this study provides evidence for a new treatment strategy in patients with a low level of consciousness, we believe that this should only be considered after appropriate assessment of the risks and benefits of this practice and further evidence from animal/experimental models that such equipment is safe and efficacious.We are grateful to Drs Esquinas and Agarawal for their comments regarding safety and outcomes issues associated with bilevel positive airway pressure (BiPAP) applied through an endotracheal tube in unconscious patients suffering from acute exacerbations of chronic obstructive pulmonary disease. In our study, only one patient developed pneumonia but survived, and two patients were shifted to the intensive care unit during the course of BiPAP therapy owing to subsequent availability of funds, and hence both patients were excluded from the final analysis. Inhospital mortality in our study was 15% (3/20), which is far lower than that in the mechanically ventilated patients with chronic obstructive pulmonary disease reported by Chandra et al1 (30%), Ai-Ping et al2 (25%), Raurich et al3 (25%), and Seneff et al4 (24%).Another issue raised was regarding leaks while administering BiPAP therapy. We connected the endotracheal tube to BiPAP via a connector with two ends, one end to the endotracheal tube and the other end to a BiPAP hosepipe. Expiratory and oxygen ports were made manually. This mechanism ensured a strongly leak-proof system.Another issue raised concerned referral of these patients to public sector hospitals. In India, the majority of government sector hospitals do not have facilities for ventilation, and there are cost constraints for poor patients at private sector hospitals. We agree that conventional BiPAP through an endotracheal tube is not the best option for patients with decreased levels of consciousness, and hybrid ventilators delivering both pressure and volume preset ventilation with other features like assisted-control mode, an alarm, and battery backup, would be a better choice, as we have already mentioned in the Discussion section of the original paper.
Authors: Divay Chandra; Jason A Stamm; Brian Taylor; Rose Mary Ramos; Lewis Satterwhite; Jerry A Krishnan; David Mannino; Frank C Sciurba; Fernando Holguín Journal: Am J Respir Crit Care Med Date: 2011-10-20 Impact factor: 21.405
Authors: S Nava; N Ambrosino; E Clini; M Prato; G Orlando; M Vitacca; P Brigada; C Fracchia; F Rubini Journal: Ann Intern Med Date: 1998-05-01 Impact factor: 25.391